Mermaid Bio Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Liquidation
Mermaid Bio General Information
Description
Developer of intracellular antibodies and drugs intended to treat unmet patient needs. The company links single-domain antibodies (nanobodies) together with advancements in drug delivery (using mRNA/LNP systems) to create a proprietary platform capable of producing medicines, enabling the healthcare sector to develop particularly effective drugs.
Contact Information
Website
www.mermaid.bioCorporate Office
- Butenandtstraße 1
- BioSysM Building
- 81377 Munich
- Germany
Corporate Office
- Butenandtstraße 1
- BioSysM Building
- 81377 Munich
- Germany
Mermaid Bio Timeline
Mermaid Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Bankruptcy: Liquidation | 07-Apr-2025 | Completed | Bankruptcy: Liquidation | |||
| 3. Early Stage VC | 24-Apr-2023 | Completed | Product In Beta Test | |||
| 2. Angel (individual) | 13-Apr-2023 | $300K | $300K | Completed | Product In Beta Test | |
| 1. Grant | 01-Jun-2022 | $233K | Completed | Product In Beta Test |
Mermaid Bio Comparisons
Industry
Financing
Details
Mermaid Bio Competitors (3)
One of Mermaid Bio’s 3 competitors is Arvinas, a Formerly VC-backed company based in New Haven, CT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arvinas | Formerly VC-backed | New Haven, CT | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Alnylam Pharmaceuticals | Formerly VC-backed | Cambridge, MA |
Mermaid Bio Patents
Mermaid Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024902175-A0 | Chimeric binding molecules | Pending | 15-Jul-2024 | ||
| WO-2024235910-A1 | Nanobody for treating inflammation, autoinflammation or cancer | Inactive | 12-May-2023 |
Mermaid Bio Signals
Mermaid Bio FAQs
-
When was Mermaid Bio founded?
Mermaid Bio was founded in 2022.
-
Where is Mermaid Bio headquartered?
Mermaid Bio is headquartered in Munich, Germany.
-
What is the size of Mermaid Bio?
Mermaid Bio has 4 total employees.
-
What industry is Mermaid Bio in?
Mermaid Bio’s primary industry is Drug Discovery.
-
Is Mermaid Bio a private or public company?
Mermaid Bio is a Private company.
-
What is Mermaid Bio’s current revenue?
The current revenue for Mermaid Bio is .
-
How much funding has Mermaid Bio raised over time?
Mermaid Bio has raised $847K.
-
Who are Mermaid Bio’s competitors?
Arvinas, Genentech, and Alnylam Pharmaceuticals are competitors of Mermaid Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process